Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis psoriatic arthritis and ankylosing spondylitis

摘要

Our aim was to evaluate the effect of adalimumab on work productivity measures, overall activity impairment, and sleep quality in patients with active moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) treated in routine care settings in Greece and determine factors associated with work impairment and sleep disturbance.